Administration of Bifidobacterium animalis subsp. lactis strain BB-12 ® in healthy children: characterization, functional composition, and metabolism of the gut microbiome

• Published in: Frontiers in microbiology 2023-05, Vol.14, p.1165771-1165771
• Main Authors: Vizioli, Carlotta, Jaime-Lara, Rosario, Daniel, Scott G, Franks, Alexis, Diallo, Ana F, Bittinger, Kyle, Tan, Tina P, Merenstein, Daniel J, Brooks, Brianna, Joseph, Paule V, Maki, Katherine A
• Format: Article
• Language: English
• Subjects: B. animalis BB-12; gut microbiome; L. delbrueckii; metagenomics; Microbiology; probiotics; S. thermophilus
• ISSN: 1664-302X; 1664-302X
• DOI: 10.3389/fmicb.2023.1165771

The consumption of probiotics may influence children's gut microbiome and metabolome, which may reflect shifts in gut microbial diversity composition and metabolism. These potential changes might have a beneficial impact on health. However, there is a lack of evidence investigating the effect of probiotics on the gut microbiome and metabolome of children. We aimed to examine the potential impact of a two ( and ; S2) three (S2 + subsp strain BB-12) strain-supplemented yogurt. Included in this study were 59 participants, aged one to five years old, recruited to phase I of a double-blinded, randomized controlled trial. Fecal samples were collected at baseline, after the intervention, and at twenty days post-intervention discontinuation, and untargeted metabolomics and shotgun metagenomics were performed. Shotgun metagenomics and metabolomic analyses showed no global changes in either intervention group's gut microbiome alpha or beta diversity indices, except for a lower microbial diversity in the S2 + BB12 group at Day 30. The relative abundance of the two and three intervention bacteria increased in the S2 and S2 + BB12 groups, respectively, from Day 0 to Day 10. In the S2 + BB12 group, the abundance of several fecal metabolites increased at Day 10, including alanine, glycine, lysine, phenylalanine, serine, and valine. These fecal metabolite changes did not occur in the S2 group. In conclusion, there were were no significant differences in the global metagenomic or metabolomic profiles between healthy children receiving two (S2) three (S2 + BB12) probiotic strains for 10 days. Nevertheless, we observed a significant increase (Day 0 to Day 10) in the relative abundance of the two and three probiotics administered in the S2 and S2 + BB12 groups, respectively, indicating the intervention had a measurable impact on the bacteria of interest in the gut microbiome. Future research using longer probiotic intervention durations and in children at risk for gastrointestinal disorders may elucidate if functional metabolite changes confer a protective gastrointestinal effect.